España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ATAI Life Sciences
ATAI
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.63
0.02
1.20%
Pre-Market: 7:38 PM EDT
15 minutes delayed
Get Report
Watch
ATAI Life Sciences (ATAI) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ATAI Life Sciences (NASDAQ:ATAI) Stock
ATAI Life Sciences Stock (NASDAQ: ATAI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 21, 2024
Cantor Fitzgerald Reiterates Overweight on AT...
Benzinga Newsdesk
Thursday, June 20, 2024
Atai Life Sciences Announced An Update On Bec...
Benzinga Newsdesk
Wednesday, June 05, 2024
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Aaron Bry
What's Going On With MindMed And Psychedelic Stocks?
Erica Kollmann
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
Friday, May 17, 2024
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
Wednesday, May 15, 2024
ATAI Life Sciences Q1 EPS $(0.17) Beats $(0.1...
Benzinga Newsdesk
Thursday, May 09, 2024
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Nina Zdinjak
Wednesday, April 24, 2024
Atai Life Sciences Disclosed Dosing Of First ...
Benzinga Newsdesk
Friday, April 19, 2024
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Caleb Naysmith
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
ATAI Life Sciences Announces the Publication ...
Benzinga Newsdesk
Thursday, April 04, 2024
Cantor Fitzgerald Reiterates Overweight on AT...
Benzinga Newsdesk
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Maxim Group Upgrades ATAI Life Sciences to Bu...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on ATAI Lif...
Benzinga Newsdesk
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Lara Goldstein
Thursday, March 28, 2024
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Lara Goldstein
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Recap: ATAI Life Sciences Q4 Earnings
Benzinga Insights
ATAI Life Sciences Q4 EPS $(0.12) Beats $(0.1...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on ATAI Lif...
Benzinga Newsdesk
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Thursday, March 07, 2024
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
atai Life Sciences Announces First Participan...
Benzinga Newsdesk
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Tuesday, February 06, 2024
atai Life Sciences Appoints Anne Johnson As C...
Benzinga Newsdesk
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Monday, January 15, 2024
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Lara Goldstein
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Monday, January 08, 2024
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
Saturday, January 06, 2024
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
Maureen Meehan
Thursday, January 04, 2024
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
Lara Goldstein
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
Lara Goldstein
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
ATAI Life Sciences Discloses Strategic Invest...
Benzinga Newsdesk
Tuesday, January 02, 2024
atai Life Sciences shares are trading higher ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
atai Life Sciences Announces Results From Sin...
Benzinga Newsdesk
Monday, January 01, 2024
Psychedelic Stock Gainers And Losers From January 1, 2024
Benzinga Insights
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
Monday, December 18, 2023
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Lara Goldstein
Show More